The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and BPC 157 for Foot Pain Houston Podiatrist Explains Compounded "semaglutide" is not FDA approved semaglutide.com FDA Peptide Update: Category 2 Removals Explained